BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
Authors:
Open Access
- 9 June 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (14) , 15650-15663
Abstract
Introduction: B‐cell lymphoma/leukemia 11B (BCL11B) is a subunit of SWI/SNF chromatin remodeling complexes and functions in cell cycle regulation and apoptosis upon DNA replication stress and damages via transcription. Many malignancies were reported to exhibit changes in BCL11B gene expression; however, no study has focused on the relationship between BCL11B and hepatocellular carcinoma, which potentially exhibits DNA replication stress and damages upon its oncogenesis. Thus, in this study, we examined the molecular characterization of BCL11B expression in hepatocellular carcinoma.Methods and Results: The cumulative progression‐free survival and overall survival were significantly longer in the clinical cases of BCL11B‐negative hepatocellular carcinoma than BCL11B‐positve cases. Microarray and real‐time PCR analyses in hepatocellular carcinoma cell lines indicated a correlation between BCL11B and GATA6, a gene reported to be correlated with oncogenic activities and resistance to anthracycline, which is often used for hepatocellular carcinoma chemotherapy. Consequently, BCL11B‐overexpressing cell lines exhibited resistance to anthracycline in cell growth assays and the resistance has been evidenced by the increased expression of BCL‐xL in cell lines. The results were supported by the analyses of human HCC samples showing the correlation between BCL11B and GATA6 expressions.Discussions and Conclusion: Our results indicated that overexpression of BCL11B amplifies GATA6 expression in hepatocellular carcinoma in vitro and in vivo that leads to anti‐apoptotic signal activation, and induces resistance to chemotherapy, which influenced the postoperative prognosis.Keywords
Funding Information
- Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
This publication has 69 references indexed in Scilit:
- Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two CasesHepatitis Monthly, 2013
- BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing SarcomaPLOS ONE, 2013
- The role of BCL11B in hematological malignancyExperimental Hematology & Oncology, 2012
- Increased Expression of Bcl11b Leads to Chemoresistance Accompanied by G1 AccumulationPLOS ONE, 2010
- Dual Role of COUP-TF-Interacting Protein 2 in Epidermal Homeostasis and Permeability Barrier FormationJournal of Investigative Dermatology, 2009
- CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor StatusPLOS ONE, 2009
- Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesisProceedings of the National Academy of Sciences, 2009
- Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary CancerPLOS Genetics, 2008
- A census of human cancer genesNature Reviews Cancer, 2004
- Homozygous deletions and point mutations of the Rit1/Bcl11b gene in γ-ray induced mouse thymic lymphomasBiochemical and Biophysical Research Communications, 2003